IONOVA/深圳原力生命科学有限公司
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
IONOVA Announces Clinical Trial Collaboration with MSD to Evaluate INV-1120 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced Solid Tumors 2022-04-29 20:00
IONOVA Life Science Announces New Financing Round of USD $100 Million 2021-08-27 22:00
1